Cargando…

Proteomic Signatures of Lifestyle Risk Factors for Cardiovascular Disease: A Cross‐Sectional Analysis of the Plasma Proteome in the Framingham Heart Study

BACKGROUND: Proteomic biomarkers related to cardiovascular disease risk factors may offer insights into the pathogenesis of cardiovascular disease. We investigated whether modifiable lifestyle risk factors for cardiovascular disease are associated with distinctive proteomic signatures. METHODS AND R...

Descripción completa

Detalles Bibliográficos
Autores principales: Corlin, Laura, Liu, Chunyu, Lin, Honghuang, Leone, Dominick, Yang, Qiong, Ngo, Debby, Levy, Daniel, Cupples, L. Adrienne, Gerszten, Robert E., Larson, Martin G., Vasan, Ramachandran S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955453/
https://www.ncbi.nlm.nih.gov/pubmed/33372532
http://dx.doi.org/10.1161/JAHA.120.018020
_version_ 1783664254913609728
author Corlin, Laura
Liu, Chunyu
Lin, Honghuang
Leone, Dominick
Yang, Qiong
Ngo, Debby
Levy, Daniel
Cupples, L. Adrienne
Gerszten, Robert E.
Larson, Martin G.
Vasan, Ramachandran S.
author_facet Corlin, Laura
Liu, Chunyu
Lin, Honghuang
Leone, Dominick
Yang, Qiong
Ngo, Debby
Levy, Daniel
Cupples, L. Adrienne
Gerszten, Robert E.
Larson, Martin G.
Vasan, Ramachandran S.
author_sort Corlin, Laura
collection PubMed
description BACKGROUND: Proteomic biomarkers related to cardiovascular disease risk factors may offer insights into the pathogenesis of cardiovascular disease. We investigated whether modifiable lifestyle risk factors for cardiovascular disease are associated with distinctive proteomic signatures. METHODS AND RESULTS: We analyzed 1305 circulating plasma proteomic biomarkers (assayed using the SomaLogic platform) in 897 FHS (Framingham Heart Study) Generation 3 participants (mean age 46±8 years; 56% women; discovery sample) and 1121 FOS (Framingham Offspring Study) participants (mean age 52 years; 54% women; validation sample). Participants were free of hypertension, diabetes mellitus, and clinical cardiovascular disease. We used linear mixed effects models (adjusting for age, sex, body mass index, and family structure) to relate levels of each inverse‐log transformed protein to 3 lifestyle factors (ie, smoking, alcohol consumption, and physical activity). A Bonferroni‐adjusted P value indicated statistical significance (based on number of proteins and traits tested, P<4.2×10(−6) in the discovery sample; P<6.85×10(−4) in the validation sample). We observed statistically significant associations of 60 proteins with smoking (37/40 top proteins validated in FOS), 30 proteins with alcohol consumption (23/30 proteins validated), and 5 proteins with physical activity (2/3 proteins associated with the physical activity index validated). We assessed the associations of protein concentrations with previously identified genetic variants (protein quantitative trait loci) linked to lifestyle‐related disease traits in the genome‐wide‐association study catalogue. The protein quantitative trait loci were associated with coronary artery disease, inflammation, and age‐related mortality. CONCLUSIONS: Our cross‐sectional study from a community‐based sample elucidated distinctive sets of proteins associated with 3 key lifestyle factors.
format Online
Article
Text
id pubmed-7955453
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-79554532021-03-17 Proteomic Signatures of Lifestyle Risk Factors for Cardiovascular Disease: A Cross‐Sectional Analysis of the Plasma Proteome in the Framingham Heart Study Corlin, Laura Liu, Chunyu Lin, Honghuang Leone, Dominick Yang, Qiong Ngo, Debby Levy, Daniel Cupples, L. Adrienne Gerszten, Robert E. Larson, Martin G. Vasan, Ramachandran S. J Am Heart Assoc Original Research BACKGROUND: Proteomic biomarkers related to cardiovascular disease risk factors may offer insights into the pathogenesis of cardiovascular disease. We investigated whether modifiable lifestyle risk factors for cardiovascular disease are associated with distinctive proteomic signatures. METHODS AND RESULTS: We analyzed 1305 circulating plasma proteomic biomarkers (assayed using the SomaLogic platform) in 897 FHS (Framingham Heart Study) Generation 3 participants (mean age 46±8 years; 56% women; discovery sample) and 1121 FOS (Framingham Offspring Study) participants (mean age 52 years; 54% women; validation sample). Participants were free of hypertension, diabetes mellitus, and clinical cardiovascular disease. We used linear mixed effects models (adjusting for age, sex, body mass index, and family structure) to relate levels of each inverse‐log transformed protein to 3 lifestyle factors (ie, smoking, alcohol consumption, and physical activity). A Bonferroni‐adjusted P value indicated statistical significance (based on number of proteins and traits tested, P<4.2×10(−6) in the discovery sample; P<6.85×10(−4) in the validation sample). We observed statistically significant associations of 60 proteins with smoking (37/40 top proteins validated in FOS), 30 proteins with alcohol consumption (23/30 proteins validated), and 5 proteins with physical activity (2/3 proteins associated with the physical activity index validated). We assessed the associations of protein concentrations with previously identified genetic variants (protein quantitative trait loci) linked to lifestyle‐related disease traits in the genome‐wide‐association study catalogue. The protein quantitative trait loci were associated with coronary artery disease, inflammation, and age‐related mortality. CONCLUSIONS: Our cross‐sectional study from a community‐based sample elucidated distinctive sets of proteins associated with 3 key lifestyle factors. John Wiley and Sons Inc. 2020-12-29 /pmc/articles/PMC7955453/ /pubmed/33372532 http://dx.doi.org/10.1161/JAHA.120.018020 Text en © 2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Corlin, Laura
Liu, Chunyu
Lin, Honghuang
Leone, Dominick
Yang, Qiong
Ngo, Debby
Levy, Daniel
Cupples, L. Adrienne
Gerszten, Robert E.
Larson, Martin G.
Vasan, Ramachandran S.
Proteomic Signatures of Lifestyle Risk Factors for Cardiovascular Disease: A Cross‐Sectional Analysis of the Plasma Proteome in the Framingham Heart Study
title Proteomic Signatures of Lifestyle Risk Factors for Cardiovascular Disease: A Cross‐Sectional Analysis of the Plasma Proteome in the Framingham Heart Study
title_full Proteomic Signatures of Lifestyle Risk Factors for Cardiovascular Disease: A Cross‐Sectional Analysis of the Plasma Proteome in the Framingham Heart Study
title_fullStr Proteomic Signatures of Lifestyle Risk Factors for Cardiovascular Disease: A Cross‐Sectional Analysis of the Plasma Proteome in the Framingham Heart Study
title_full_unstemmed Proteomic Signatures of Lifestyle Risk Factors for Cardiovascular Disease: A Cross‐Sectional Analysis of the Plasma Proteome in the Framingham Heart Study
title_short Proteomic Signatures of Lifestyle Risk Factors for Cardiovascular Disease: A Cross‐Sectional Analysis of the Plasma Proteome in the Framingham Heart Study
title_sort proteomic signatures of lifestyle risk factors for cardiovascular disease: a cross‐sectional analysis of the plasma proteome in the framingham heart study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955453/
https://www.ncbi.nlm.nih.gov/pubmed/33372532
http://dx.doi.org/10.1161/JAHA.120.018020
work_keys_str_mv AT corlinlaura proteomicsignaturesoflifestyleriskfactorsforcardiovasculardiseaseacrosssectionalanalysisoftheplasmaproteomeintheframinghamheartstudy
AT liuchunyu proteomicsignaturesoflifestyleriskfactorsforcardiovasculardiseaseacrosssectionalanalysisoftheplasmaproteomeintheframinghamheartstudy
AT linhonghuang proteomicsignaturesoflifestyleriskfactorsforcardiovasculardiseaseacrosssectionalanalysisoftheplasmaproteomeintheframinghamheartstudy
AT leonedominick proteomicsignaturesoflifestyleriskfactorsforcardiovasculardiseaseacrosssectionalanalysisoftheplasmaproteomeintheframinghamheartstudy
AT yangqiong proteomicsignaturesoflifestyleriskfactorsforcardiovasculardiseaseacrosssectionalanalysisoftheplasmaproteomeintheframinghamheartstudy
AT ngodebby proteomicsignaturesoflifestyleriskfactorsforcardiovasculardiseaseacrosssectionalanalysisoftheplasmaproteomeintheframinghamheartstudy
AT levydaniel proteomicsignaturesoflifestyleriskfactorsforcardiovasculardiseaseacrosssectionalanalysisoftheplasmaproteomeintheframinghamheartstudy
AT cupplesladrienne proteomicsignaturesoflifestyleriskfactorsforcardiovasculardiseaseacrosssectionalanalysisoftheplasmaproteomeintheframinghamheartstudy
AT gersztenroberte proteomicsignaturesoflifestyleriskfactorsforcardiovasculardiseaseacrosssectionalanalysisoftheplasmaproteomeintheframinghamheartstudy
AT larsonmarting proteomicsignaturesoflifestyleriskfactorsforcardiovasculardiseaseacrosssectionalanalysisoftheplasmaproteomeintheframinghamheartstudy
AT vasanramachandrans proteomicsignaturesoflifestyleriskfactorsforcardiovasculardiseaseacrosssectionalanalysisoftheplasmaproteomeintheframinghamheartstudy